Lyell Immunopharma Inc. (LYEL)
NASDAQ: LYEL
· Real-Time Price · USD
0.41
0.01 (1.33%)
At close: May 14, 2025, 3:59 PM
0.39
-3.82%
After-hours: May 14, 2025, 04:20 PM EDT
1.33% (1D)
| Bid | 0.38 |
| Market Cap | 119.76M |
| Revenue (ttm) | 61K |
| Net Income (ttm) | -342.99M |
| EPS (ttm) | -1.31 |
| PE Ratio (ttm) | -0.31 |
| Forward PE | -0.66 |
| Analyst | Hold |
| Ask | 0.46 |
| Volume | 212,902 |
| Avg. Volume (20D) | 817,400 |
| Open | 0.40 |
| Previous Close | 0.40 |
| Day's Range | 0.40 - 0.41 |
| 52-Week Range | 0.39 - 2.88 |
| Beta | -0.26 |
About LYEL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LYEL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LYEL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+19.35%
Lyell Immunopharma shares are trading higher. The ...
Unlock content with
Pro Subscription
6 months ago
-5.22%
Lyell Immunopharma shares are trading higher after the company announced it will acquire privately-owned clinical-stage biotechnology company ImmPACT Bio.
